The Risk of Hypercoagulability in Ovarian Hyperstimulation Syndrome
Ovarian hyperstimulation syndrome (OHSS) is a rare and potentially life-threatening complication of infertility treatment occurring during either the luteal phase or early pregnancy. An increasing number of thromboembolic complications associated with the increased use of assisted reproductive techn...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sestre Milosrdnice University hospital, Institute of Clinical Medical Research
2015-01-01
|
| Series: | Acta Clinica Croatica |
| Subjects: | |
| Online Access: | http://hrcak.srce.hr/file/214305 |
| _version_ | 1818346843740831744 |
|---|---|
| author | Damir Danolić Miro Kasum Mario Puljiz Ilija Alvir Darko Tomica Ivica Mamić Ermin Čehić Ivan Bolanča |
| author_facet | Damir Danolić Miro Kasum Mario Puljiz Ilija Alvir Darko Tomica Ivica Mamić Ermin Čehić Ivan Bolanča |
| author_sort | Damir Danolić |
| collection | DOAJ |
| description | Ovarian hyperstimulation syndrome (OHSS) is a rare and potentially life-threatening complication of infertility treatment occurring during either the luteal phase or early pregnancy. An increasing number of thromboembolic complications associated with the increased use of assisted reproductive techniques have been reported in the literature. Identification of the risk factors is crucial for prevention of thromboembolic events in OHSS patients. Alterations in the hemostatic system cause hypercoagulability in women affected by severe OHSS. Coexistence of inherited hypercoagulable conditions increases the risk of thromboembolism. The role of clinical parameters that can help predict development of thrombosis is controversial. Patients with a personal or family history of thrombosis undergoing infertility treatment should be considered for thrombophilia screening, while routine examination of inherited thrombophilic mutations is not indicated in infertile patients. Antithrombotic primary prevention is not indicated in healthy women undergoing assisted reproductive procedures or in women with thrombophilia. Anticoagulant therapy is indicted if there is clinical evidence of thrombosis or laboratory evidence of hypercoagulability. In this review, the risks of hypercoagulability in the OHSS are discussed. |
| first_indexed | 2024-12-13T17:24:43Z |
| format | Article |
| id | doaj.art-8a733e6b2a8448b18ae6b77819a6237e |
| institution | Directory Open Access Journal |
| issn | 0353-9466 1333-9451 |
| language | English |
| last_indexed | 2024-12-13T17:24:43Z |
| publishDate | 2015-01-01 |
| publisher | Sestre Milosrdnice University hospital, Institute of Clinical Medical Research |
| record_format | Article |
| series | Acta Clinica Croatica |
| spelling | doaj.art-8a733e6b2a8448b18ae6b77819a6237e2022-12-21T23:37:13ZengSestre Milosrdnice University hospital, Institute of Clinical Medical ResearchActa Clinica Croatica0353-94661333-94512015-01-0154.2.186191The Risk of Hypercoagulability in Ovarian Hyperstimulation SyndromeDamir Danolić0Miro Kasum1Mario Puljiz2Ilija Alvir3Darko Tomica4Ivica Mamić5Ermin Čehić6Ivan Bolanča7Department of Gynecologic Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, CroatiaClinical Department of Obstetrics and Gynecology, Zagreb University Hospital Center, Zagreb, CroatiaDepartment of Gynecologic Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, CroatiaDepartment of Gynecologic Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, CroatiaDepartment of Gynecologic Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, CroatiaDepartment of Gynecologic Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital Center, Zagreb, CroatiaDepartment of Obstetrics and Gynecology, Zenica Cantonal Hospital, Zenica, Bosnia and HerzegovinaClinical Department of Obstetrics and Gynecology, Sestre milosrdnice University Hospital Center, Zagreb, CroatiaOvarian hyperstimulation syndrome (OHSS) is a rare and potentially life-threatening complication of infertility treatment occurring during either the luteal phase or early pregnancy. An increasing number of thromboembolic complications associated with the increased use of assisted reproductive techniques have been reported in the literature. Identification of the risk factors is crucial for prevention of thromboembolic events in OHSS patients. Alterations in the hemostatic system cause hypercoagulability in women affected by severe OHSS. Coexistence of inherited hypercoagulable conditions increases the risk of thromboembolism. The role of clinical parameters that can help predict development of thrombosis is controversial. Patients with a personal or family history of thrombosis undergoing infertility treatment should be considered for thrombophilia screening, while routine examination of inherited thrombophilic mutations is not indicated in infertile patients. Antithrombotic primary prevention is not indicated in healthy women undergoing assisted reproductive procedures or in women with thrombophilia. Anticoagulant therapy is indicted if there is clinical evidence of thrombosis or laboratory evidence of hypercoagulability. In this review, the risks of hypercoagulability in the OHSS are discussed.http://hrcak.srce.hr/file/214305Ovarian hyperstimulation syndromeThrombophiliaThrombosis |
| spellingShingle | Damir Danolić Miro Kasum Mario Puljiz Ilija Alvir Darko Tomica Ivica Mamić Ermin Čehić Ivan Bolanča The Risk of Hypercoagulability in Ovarian Hyperstimulation Syndrome Acta Clinica Croatica Ovarian hyperstimulation syndrome Thrombophilia Thrombosis |
| title | The Risk of Hypercoagulability in Ovarian Hyperstimulation Syndrome |
| title_full | The Risk of Hypercoagulability in Ovarian Hyperstimulation Syndrome |
| title_fullStr | The Risk of Hypercoagulability in Ovarian Hyperstimulation Syndrome |
| title_full_unstemmed | The Risk of Hypercoagulability in Ovarian Hyperstimulation Syndrome |
| title_short | The Risk of Hypercoagulability in Ovarian Hyperstimulation Syndrome |
| title_sort | risk of hypercoagulability in ovarian hyperstimulation syndrome |
| topic | Ovarian hyperstimulation syndrome Thrombophilia Thrombosis |
| url | http://hrcak.srce.hr/file/214305 |
| work_keys_str_mv | AT damirdanolic theriskofhypercoagulabilityinovarianhyperstimulationsyndrome AT mirokasum theriskofhypercoagulabilityinovarianhyperstimulationsyndrome AT mariopuljiz theriskofhypercoagulabilityinovarianhyperstimulationsyndrome AT ilijaalvir theriskofhypercoagulabilityinovarianhyperstimulationsyndrome AT darkotomica theriskofhypercoagulabilityinovarianhyperstimulationsyndrome AT ivicamamic theriskofhypercoagulabilityinovarianhyperstimulationsyndrome AT ermincehic theriskofhypercoagulabilityinovarianhyperstimulationsyndrome AT ivanbolanca theriskofhypercoagulabilityinovarianhyperstimulationsyndrome AT damirdanolic riskofhypercoagulabilityinovarianhyperstimulationsyndrome AT mirokasum riskofhypercoagulabilityinovarianhyperstimulationsyndrome AT mariopuljiz riskofhypercoagulabilityinovarianhyperstimulationsyndrome AT ilijaalvir riskofhypercoagulabilityinovarianhyperstimulationsyndrome AT darkotomica riskofhypercoagulabilityinovarianhyperstimulationsyndrome AT ivicamamic riskofhypercoagulabilityinovarianhyperstimulationsyndrome AT ermincehic riskofhypercoagulabilityinovarianhyperstimulationsyndrome AT ivanbolanca riskofhypercoagulabilityinovarianhyperstimulationsyndrome |